Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A straightforward, step-by-step budgeting tool introduction that helps you plan expenses, adjust forecasts, and save more.
16,528 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Nokomis Capital quietly builds a new position in Apple Hospitality REIT, underscoring a rising appetite for hospitali...
A bold stand against dumbing down, Jennifer Siebel Newsom’s path shows that staying true to your credentials can boos...
Wall Street and crypto traders watch a quiet moment for Bitcoin as geopolitical tensions cool and ETF inflows grow. T...
Wyden announces VALR will join its global liquidity network, unlocking African market liquidity for banks and brokers...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
What if you could turn rental properties into a reliable income stream in just a few years? This guide shares five pr...
The Senate delivers a bipartisan win with the ROAD to Housing Act, yet observers say the measure only scratches the s...
Tether, the issuer of the USDT stablecoin, has hired a Big Four firm to perform its first comprehensive audit, aiming...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Ethereum is the lone red stake among the top-10 cryptos this week, while Bitcoin and other large caps post gains as i...